Back
Hua Medicine (Shanghai) Ltd. (02552.HK) Price
02552.HK Stock Price Chart
HUA MEDICINE-B (02552.HK)
Hua Medicine (Shanghai) Ltd.
HK$3.25
-4.69%
$-0.16
CLOSED_MARKET: Jan 16, 16:00:00 HKT
Key Stats
Prev.Close
$3.41
Open
$3.41
Day's Range
$3.2 - $3.41
52 week range
$1.24 - $4.95
Volume
5.3M
Avg.Volume
3.5M
EPS (TTM)
1.21
Dividend yield
--
Market Cap
$3.2B
What is HUA MEDICINE-B?
Hua Medicine Ltd. provides drug discovery and development services. The company is headquartered in Shanghai, Shanghai and currently employs 285 full-time employees. The company went IPO on 2018-09-14. The firm is also engaged in the commercialization of HuaTangNing products. The Company’s main product pipeline dorzagliatin or HMS5552 is a glucokinase activator or GKA, designed to control the progressive degenerative nature of diabetes by restoring glucose homeostasis in Type 2 diabetes. The firm mainly conducts its business in the domestic market.
Features
Trading Strategies
Resources
© 2025 Finture Development Limited. All rights reserved
